Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors
NCT04901806
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
29
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor terminated development of PBI-200
Conditions
Solid Tumor, Adult
Brain Tumor, Primary
Desmoplastic Small Round Cell Tumor
Interventions
DRUG:
PBI-200
Sponsor
Pyramid Biosciences